Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection
doi: 10.1002/hep.22379
pmid: 18712791
Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection
Abstract Both strong antigenic avidity and acquisition of proper effector functions contribute to the efficacy of antiviral T cell responses. To correlate these parameters with the outcome of hepatitis C virus (HCV) infection, we characterized HCV-specific CD8 T cell lines isolated after immunomagnetic sorting of peripheral blood mononuclear cells from human leukocyte antigen A*02 (HLA-A*02) individuals with various HCV serological statuses, using recombinant HLA-A*0201 multimers loaded with three immunodominant HCV genotype 1-derived epitopes. CD8 T cells specific for these three epitopes were derived from most HLA-A*0201 individuals, regardless of their HCV serology or clinical outcome. Donors recovered from genotype 1 HCV infection were enriched for high-avidity T cells with enhanced interferon gamma (IFN-γ), tumor necrosis factor alpha, and cytotoxic T lymphocyte responses, when compared with seronegative donors and seropositive patients infected with irrelevant HCV genotypes. Patients chronically infected with genotype 1 strain yielded almost exclusively low-avidity T cells, whose hyporesponsiveness was primarily attributable to low T cell receptor (TCR) avidity rather than intrinsic functional defects. Conclusion: This study suggests that strong IFN-γ responses associated with efficient viral clearance primarily result from Ag-driven selection/survival of HCV-specific T cells expressing high-avidity TCR. It also suggests a link between the quality of the initial HCV-specific T cell repertoire and susceptibility to chronic infection. (Hepatology 2008.)
- Institut Pasteur France
- Inserm France
- University of Angers France
- University of Nantes France
- French Institute of Health and Medical Research France
Immunity, Cellular, [SDV.IMM] Life Sciences [q-bio]/Immunology, Genotype, HLA-A Antigens, Tumor Necrosis Factor-alpha, Antibody Affinity, Receptors, Antigen, T-Cell, 610, Epitopes, T-Lymphocyte, Hepacivirus, CD8-Positive T-Lymphocytes, Hepatitis C, Cell Line, Interferon-gamma, Case-Control Studies, 616, HLA-A2 Antigen, [SDV.IMM]Life Sciences [q-bio]/Immunology, Humans, T-Lymphocytes, Cytotoxic
Immunity, Cellular, [SDV.IMM] Life Sciences [q-bio]/Immunology, Genotype, HLA-A Antigens, Tumor Necrosis Factor-alpha, Antibody Affinity, Receptors, Antigen, T-Cell, 610, Epitopes, T-Lymphocyte, Hepacivirus, CD8-Positive T-Lymphocytes, Hepatitis C, Cell Line, Interferon-gamma, Case-Control Studies, 616, HLA-A2 Antigen, [SDV.IMM]Life Sciences [q-bio]/Immunology, Humans, T-Lymphocytes, Cytotoxic
12 Research products, page 1 of 2
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
chevron_left - 1
- 2
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).59 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
